Effective SGLT2 Inhibitor for Patient with Type 2 Diabetes Mellitus (T2DM) and Depression

• Shimizu, E

• Takehisa, Y

• Bando, Hiroshi

• Fujita, M

• Kusaka, Y

• Yuu, M

抄録

The case was a 55-year-old female patient with depression for 5 years and type 2 diabetes mellitus (T2DM) for 3 years. She has received anti-depressant and anti-hyperglycemic agents (OHAs). Approximately 1 year ago, her diabetic control became exacerbated without specific triggers. She was started to given Ipragliflozin L-Proline as Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. After that, her glucose variability and depression had been improved. According to the previous reports, SGLT-2 inhibitors seem to have anti-depression efficacy for diabetes. The case has been followed up in detail, and this report is expected to be a useful reference for diabetes care.

収録刊行物

• Diabetes Research : Open Access

  Diabetes Research : Open Access 2 (S1), 26-32, 2020-04-14

  Asploro

キーワード

• Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor
• Ipragliflozin L-Proline
• Depression
• Oral Hypoglycemic Agents (OHA)
• Low-Carbohydrate Diet (LCD)

詳細情報

• CRID: 1050848249733363200
• NII論文ID: 120006849728
• Web Site: http://repo.lib.tokushima-u.ac.jp/114810
• 本文言語コード: en
• 資料種別: journal article
• データソース種別:
  • IRDB
  • CiNii Articles